AGENNIX
Agennix AG is a publicly traded biopharmaceutical company that is developing novel therapies in areas of major unmet medical need to improve the length and quality of life of seriously ill patients. The Company's most advanced program is talactoferrin, an oral targeted therapy that has demonstrated activity in randomized, double-blind, placebo-controlled Phase 2 studies in non-small cell lung cancer as well as in severe sepsis. Talactoferrin is currently in Phase 3 clinical trials in non-small c... ell lung cancer. Other clinical development programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1 testing; the oral platinum-based compound satraplatin; and a topical gel form of talactoferrin for diabetic foot ulcers. Agennix's registered seat is in Heidelberg, Germany. The Company has three sites of operation: Martinsried/Munich, Germany; Princeton, New Jersey and Houston, Texas.
AGENNIX
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
1993-01-01
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.agennix.com
Total Employee:
51+
Status:
Closed
Contact:
+49 89 85 65 2600
Total Funding:
139.6 M USD
Technology used in webpage:
Product Schema Offer Schema Microdata For Google Shopping Brand Schema Shopify Shopify Hosted Namecheap DNS Placeholder
Similar Organizations
Astra Pharmaceuticals
AstraZeneca is a global, science-led biopharmaceutical business.
Aztiq
Aztiq is a long-term investment fund based in Iceland and focuses on pharmaceuticals, real estate, arts & culture
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
DNX Biopharmaceuticals
DNX is a biopharmaceutical company.
Galenica
Galenica is a pharmaceutical company.
Grespo AB
Grespo AB is a biomedical company based in Stockholm
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Med Discovery
Med Discovery is a Swiss biopharmaceutical company.
ProStrakan
ProStrakan is a pharmaceutical company.
SignaBlok
SignaBlok is a biopharmaceutical company.
Current Advisors List
Board_member
2011-12-31
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-11-05 | GPC Biotech | GPC Biotech acquired by Agennix | N/A |
Official Site Inspections
http://www.agennix.com
- Host name: myshopify.com
- IP address: 23.227.38.65
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Agennix"
Agennix - Crunchbase Company Profile & Funding
Agennix AG is a publicly traded biopharmaceutical company that is developing novel therapies in areas of major unmet medical need to improve the length …See details»
Agennix AG - Heidelberg, Germany - bionity.com
Agennix AG is a publicly traded biopharmaceutical company developing novel therapeutics for indications with significant unmet medical need to achieve improved longevity and quality of …See details»
Company Agennix AG - MarketScreener.com
Agennix AG is a Germany-based biopharmaceutical company. The Company focuses on the development of therapies, which improve the lives of critically ill patients in areas of major …See details»
Agennix Careers and Employment | Indeed.com
Oct 2, 2012 Agennix is a global company based out of Germany with it's pharmaceutical R&D in Princeton, NJ. The global presence provides support for working internationally. Although the …See details»
Award - SBIR
Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https:// means …See details»
Agennix AG - M&A Summary and Business Overview - Mergr
Agennix AG is a biopharmaceutical company. The Company’s clinical development programs include oral talactoferrin alfa; a topical gel form of talactoferrin and RGB-286638, a multi …See details»
GPC Biotech AG (GPCG.DE) and Agennix Announce Proposed …
Feb 18, 2009 The merger combines GPC Biotech's and Agennix's oncology pipelines, including Agennix's Phase 3 novel oncology therapy, talactoferrin, with the clinical development and …See details»
Agennix AG | Biotechnology - The Pharmaletter
Pharmaceutical company Agennix AG (Frankfurt: AGX) is a drug development company focused on oncology. The company' s lead investigational agent is oral talactoferrin alfa (talactoferrin). …See details»
Agennix AG, Heidelberg - HRB 707984 Amtsgericht Mannheim
Agennix AG in Heidelberg, Gesellschafter, Management, Netzwerk, Jahresabschlüsse, Bekanntmachungen - Forschung, Entwicklung und Herstellung von pharmazeutischen und …See details»
Organization | Agennix
Agennix Report issue. For profit Phase 1 Phase 2 Phase 3. Founded: Planegg United States (1997 ... Organization Overview. First Clinical Trial. 2003 NCT00069745. First Marketed Drug. …See details»
Agennix AG | Insights
May 23, 2013 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Unternehmen Agennix AG - MarketScreener.com
Agennix AG ist ein biopharmazeutisches Unternehmen mit Sitz in Deutschland. Das Unternehmen konzentriert sich auf die Entwicklung von Therapien, die das Leben schwerkranker Patienten …See details»
Lonza and Agennix Sign Development and Manufacturing Deal for ...
Apr 12, 2012 Lonza and Agennix AG announced an agreement for the production of Agennix’s first-in-class oral Dendritic Cell Mediated Immunotherapy (DCMI), talactoferrin, currently in …See details»
Agennix Receives Fast Track Designation From FDA for …
May 19, 2009 Agennix's RCC submission included the results from a Phase I trial, and a multi-center, single arm Phase II trial of talactoferrin in 44 patients with clear cell RCC who had …See details»
GPC, Agennix get $20M to fuel merger - Fierce Biotech
Feb 18, 2009 In the deal, GPC is being merged into a new company which will have all of Agennix's shares along with 15 million euros--$20 million--injected by an investment company …See details»
Agennix AG (Agennix AG) - 药物管线_专利_临床试验_投融营收_最 …
了解Agennix AG (Agennix AG)公司的药物管线，治疗领域，技术平台，以及它的22项临床试验, 7篇新闻和87篇文献，疾病领域:肿瘤，血液及淋巴系统疾病，免疫系统疾病，技术平台:小分 …See details»
Talactoferrin alfa (Agennix AG) (Talactoferrin alfa (Agennix AG)) - _ …
Abstract Iron-deficiency anemia (IDA) affects many infants in low- and middle-income countries (LMICs) and may impair cognitive development and adaptive immunity. Effective interventions …See details»
Stem Cell Innovations to Provide Research and Assay Services to …
Mar 3, 2010 Agennix AG is a publicly traded biopharmaceutical company that is developing novel therapies in areas of major unmet medical need to improve the length and quality of life …See details»
Agenix AI Solutions for SMBs
Agenix offers AI solutions for SMBs. Transform your operational efficiency and customer engagement through custom AI technology. From Text / Voice AI agents to custom Internal …See details»
AGENIX
Your AI-Powered Assistant for Crypto and DeFi. AGENIX AI is a next-generation platform offering six specialized AI agents to empower your crypto journey.See details»